View Single Post
Old Fri May 27, 2016, 12:10 PM
Data Data is offline
Join Date: Sep 2014
Location: Florida
Posts: 245

The consent form clearly stated there was no direct benefit to me but the indirect benefit is I am learn whether I am likely to relapse or not and the lenalidomide could stall that for a while.

As far as the chimerism test, this isn't the one that is done routinely after a transplant. It was one that was developed at UF Health and is supposed to be much more accurate and predict relapse.


Prostate Cancer: Treated in early 2013 with HDR Brachytherapy. MDS-RCMD: Oct 2014. Biopsies: 46,XY,t(7;18)[2]: 46,XY,del(7)( q22)[3]: 45,XY,-7[6]: 45,XY,-7[10]: 45,XY,-7[13]. HSCT in April 2016.

Last edited by Data : Fri May 27, 2016 at 03:37 PM.
Reply With Quote